SUMMARY ANSWER: Semen quality in most HIV-infected patients under antiretroviral treatment exceeds WHO limits, but the number falling below them is higher than would be expected in a healthy population. Exposure to efavirenz has a significant association with dysmotility.
Introduction
The extremely low probability of sexual and vertical transmission of HIV, thanks to effective antiretroviral therapy of infected people (Del Romero et al., 2010; Cohen et al., 2011; Mandelbrot et al., 2015) , has led increasing number of HIV-serodiscordant couples (SDCs) to wish to have children (Del Romero et al., 2016) .
Multiple studies with different designs have yielded contradictory results about the potential impact of HIV infection on semen (Nicopoullos et al., 2004; Garrido et al., 2005; Bujan et al., 2007; Lorusso et al., 2010; Kehl et al., 2011) . Although CD4 + lymphocyte count has been associated with seminal alterations (Muller et al., 1998; Dulioust et al., 2002; Nicopoullos et al., 2011) , other specific disease markers such as CD4 + nadir, highest viral load achieved and clinical stage have been poorly analysed (Pilatz et al., 2014) . Regarding antiretroviral therapy, recent reports have related some alterations to treatment with non-nucleoside reverse transcriptase inhibitors, specifically, efavirenz (Lambert-Niclot et al., 2011; Frapsauce et al., 2015) . The aim of this study was 2-fold: to compare the semen parameters of a group of HIV-positive males under antiretroviral therapy with WHO 2010 reference values (WHO, 2010) , and to identify the factors influencing the presence of possible alterations.
Materials and Methods

Patients
The study population consisted of 139 HIV-infected men under antiretroviral therapy, members of SDCs, who attended a free public clinic for sexually transmitted infections (STIs) 
Laboratory tests
Current CD4 + lymphocytes were determined by flow cytometry and HIV viral load by techniques of signal amplification ('branched-DNA') or polymerase chain reaction ('real-time k PCR'). Syphilis was evaluated by reagin ('RPR') and treponemal tests ('ELISA' and 'TPPA' or 'FTA-abs'). Other STIs were investigated by urethral exudates ('cultures and PCR'). HBV/ HCV serologies were performed by ELISA and HCV viral load by polymerase chain reaction ('real-time k PCR'). The semen samples were collected in the laboratory by masturbation after 3-5 days of abstinence. After 30 min, the spermiograms were performed through traditional analysis by two trained biologists, according to the WHO recommendations published in 1999 (WHO, 1999 . Total motility was classified as progressive or non-progressive and morphology as normal or abnormal (head, tail and midpiece abnormalities) following Menkveld's criteria, (Menkveld et al., 1990) recommended and confirmed in the 1999 and 2010 WHO manuals, respectively (WHO, 1999 (WHO, , 2010 Only cocaine, except for two men who also consumed ecstasy and amphetamines. c Positive serology and detectable viral load of hepatitis C virus. 
Statistical analysis
A descriptive analysis including sociodemographic, behavioural and clinical characteristics was performed. To compare semen characteristics of the study population with the WHO 2010 reference group (WHO, 2010) , the Fisher exact test was applied, classifying the patients as being below or above the lower fifth percentile. Statistical comparisons were performed using the chi-square or Fisher statistic to determine whether there were significant differences in the profile of HIV-positive men who presented any alteration in their semen parameters and those who did not. Finally, associations were studied by bivariate and multivariate analysis, and crude/adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated. Statistical analyses were performed by SPSS-PASW 18 for Windows. P < 0.05 was considered statistically significant. Table I shows the sociodemographic, behavioural and clinical characteristics of 139 HIV-positive males under stable antiretroviral therapy for whom a sperm analysis was performed. Table II shows the median and interquartile range (IQR) of semen parameters analysed in the spermiograms (see Fig. 1 ) and the comparison of the seminal parameters of the study population with WHO 2010 reference values. Although the medians of all the assessed semen parameters were within normal range, up to 19% of patients revealed values below the lower reference limit indicated by the lower fifth percentiles: progressive sperm motility (18.7%, P = 0.002), total sperm count (18.0%, P = 0.003) and semen volume (15.8%, P = 0.012).
Results
Patients' characteristics
Semen characteristics
Association between sociodemographic/ behavioural/clinical factors and seminal impairment
The bivariate analysis looking for the possible relationship between sociodemographic, behavioural and clinical factors of patients that could have some impact on semen and impaired semen parameters identified a significant association between asthenospermia and current treatment with efavirenz: 28% of patients receiving efavirenz had asthenospermia versus 11% of those who did not receive it (P = 0.012, Table III ). The binary logistic regression analysis revealed that treatment with efavirenz increases the risk of having reduced sperm motility. This effect was independent of age, toxic consumption, past use of injecting drugs, recent or past STI, clinical stage, current and nadir CD4 + , active HCV coinfection, time since diagnosis of HIV infection and time under antiretroviral therapy (adjusted OR = 5.11, 95% CI : 1.36-19.26, P = 0.016, Table IV ). The results remained statistically significant when CIs at 96-98% were considered (data not shown). The association between low total sperm count and efavirenz treatment revealed by the initial bivariate analysis did not remain after the multivariate analysis (adjusted OR = 0.62, 95% CI: 0.16-2.43, P = 0.491). No significant association was shown between low semen volume and any of the tested variables.
Discussion
We investigated semen quality in HIV-positive men under stable antiretroviral therapy who requested, along with their HIV-negative partners, reproductive counselling in a free public clinic for STIs in Madrid. The results were compared with a large data set from the WHO 2010 reference group of proven fertile men (WHO, 2010) , in accordance with the WHO recommendation for the investigation of male factor infertility (Cooper et al., 2010 The limits used are derived from the fifth centile of men who fathered a child within the previous 12 months. c Fisher's exact test comparing WHO 2010 reference group and HIV-positive patients based on lower fifth percentiles. Significance of P-value < 0.05. to 19% of patients had below normal values for progressive sperm motility, total sperm count and sperm volume. A significant association between treatment with efavirenz and the presence of dysmotility was identified.
The differences in published results regarding seminal changes in HIV-positive patients (Muller et al., 1998; Dulioust et al., 2002; Diehl et al., 2003; Nicopoullos et al., 2004; Garrido et al., 2005; Bujan et al., 2007; Kehl et al., 2011) may be due, among other factors, to differences in the fertility status of participants in control groups, to methodological changes in semen analysis or to the proportion of patients who were on antiretroviral therapy. Pilatz et al. also compared 116 HIV-positive patients, all of them under antiretroviral therapy, with WHO 2010 reference values and found that, although the median values of all standard semen parameters analysed were within the normal range, a significant percentage of patients,~25%, had sperm parameters (volume, concentration, total count, progressive motility and normal morphology) below the fifth percentile (Pilatz et al., 2014) . Although the patients studied by Pilatz et al. were probably different from those requesting advice for safe procreation in the present work, we found median values for some sperm parameters similar to those described by the aforementioned authors: volume, pH and sperm concentration. However, other parameters, like percentage of progressive motility and especially of normal morphology, were higher in our series. To limit the deleterious effects of dehydration, pH or changes in temperature on motility, all our sperm samples were collected in the laboratory, and sperm motility was assessed exactly 30 min after liquefaction, which the WHO recommends as preferable, although assessment within up to 1 h of ejaculation is considered acceptable (WHO, 2010) .
Sperm morphology analysis, despite adherence to the method in the WHO laboratory manual, remains subjective in most cases, and is difficult to standardize, since it attempts to draw an artificial cut-off point between normal and abnormal sperm. However, the studies included to provide reference values were conducted in different regions of the world, with some areas under-represented. Differences may represent, in addition to laboratory-dependent biases of measurement, real biological differences among men in different regions (Cooper et al., 2010) .
Our series shows that former users of intravenous drugs constituted the most prevalent profile of male members of SDCs who requested reproductive counselling and therefore they had a high prevalence of coinfection with hepatitis C virus, factors that might be related to sperm impairment (Lorusso et al. 2010) . Nevertheless, our data showed that only exposure to efavirenz significantly increased the risk of having reduced progressive motility. This association was maintained after adjusting for other potential confounding variables that no other study has evaluated jointly. Our results are consistent with some other studies that have showed an association between efavirenz exposure and impaired sperm motility. Among the mechanisms hypothesized to explain this relationship are abnormal seminal plasma composition, flagellar dysfunction, mitochondrial toxicity and alterations of vitamin D-dependent processes during sperm maturation (Lambert-Niclot et al., 2011; Frapsauce et al., 2015) .
These results do not demonstrate a causal relationship between exposure to efavirenz and decreased sperm motility, thus further studies evaluating the relationship of this condition and the potential deleterious effects of this medication are necessary to clarify the underlying mechanisms and the real impact on natural fertility.
Conclusion
In summary, while there are conflicting data on this subject, our study strengthens the evidence that semen quality remains normal in most HIV-positive men under antiretroviral therapy, but is sub-normal in a small, but greater than expected, proportion of them. We observed a significant association between impaired motility and exposure to efavirenz. Since efavirenz is still widely used in current therapeutic regimens, our results may affect many seropositive men who desire procreation.
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